drugset / Trial / NCT06610734
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Phase 2
Recruiting
202 enrolled
Sichuan University
Shanghai Shengdi Pharmaceutical Co., Ltd · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined with Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Timeline
- Start
- 2024-12-23
- Primary completion
- 2026-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Adebrelimab | Monoclonal antibody | — | — |